Hoth Therapeutics Shares Major Pipeline Updates: W...
Category : Clinical Trial Update 4 December 2025Hoth Therapeutics has released a detailed update on its clinical and preclinical programs. The compa...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Recross Cardio Achieves First Clinical Implantatio...
Category : Clinical Trial Update 4 December 2025Recross Cardio Inc., a structural heart company developing next-generation membrane-based sealing te...
ADC Therapeutics to Share New Data on LOTIS-7 Tria...
Category : Clinical Trial Update 3 December 2025ADC Therapeutics is preparing to reveal fresh clinical insights on its ongoing LOTIS-7 Phase 1b tria...
EMA’s Positive PIP Decision Clears New Path for AO...
Category : Clinical Trial Update 3 December 2025AOB Pharma, Inc. (AOBiome) has secured a major regulatory milestone for its lead topical therapeutic...
FDA Expands Dosing Options for OMLYCLO: What the N...
Category : Approval/Launch 3 December 2025The FDA has approved a new 300 mg/2 mL prefilled syringe presentation of OMLYCLO® (omalizumab-ig...
Latest Newsletter Post
-
Recross Cardio Achieves First Clini..
4 December 2025
-
Hoth Therapeutics Shares Major Pipe..
4 December 2025
-
FDA Expands Dosing Options for OMLY..
3 December 2025
-
EMA’s Positive PIP Decision Clears..
3 December 2025
-
ADC Therapeutics to Share New Data..
3 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com